Medtronic PLC (N:MDT)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 20 On Hatch, Hatch Street Lower
Tel: 1-763-5052692
IR: See website
Key People
Omar Syed Ishrak
Chairman of the Board, Chief Executive Officer
Bradley E. Lerman
Senior Vice President, General Counsel, Corporate secretary
Karen L. Parkhill
Chief Financial Officer, Executive Vice President
Carol A. Surface
Chief Human Resource Officer, Senior Vice President
Michael J. Coyle
Executive Vice President, Group President - Cardiac and Vascular Group
Hooman C. Hakami
Executive Vice President and Group President of the Diabetes Group
Robert ten Hoedt
Executive Vice President and President - EMEAC
Geoffrey S. Martha
Executive Vice President and President - Restorative Therapies Group
Robert S. White
Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group
Richard E. Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Business Overview
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.
Financial Overview
For the fiscal year ended 26 April 2019, Medtronic PLC revenues increased 2% to $30.56B. Net income before extraordinary items decreased 17% to $4.59B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Gain on sale of businesses decrease from $697M (income) to $0K, Interest Expense increase of 26% to $1.44B (expense), Restructuring charges.
Employees: 86,000 as of Apr 27, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $148,715M as of Apr 26, 2019
Annual revenue (TTM): $30,557M as of Apr 26, 2019
EBITDA (TTM): $9,570M as of Apr 26, 2019
Net annual income (TTM): $4,591M as of Apr 26, 2019
Free cash flow (TTM): $3,180M as of Apr 26, 2019
Net Debt Last Fiscal Year: $15,476M as of Apr 26, 2019
Shares outstanding: 1,340,697,595 as of Apr 26, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization